Advanced search
Publication Cover
Clinical Toxicology Volume 57, 2019 - Issue 7
Submit an article Journal homepage
2,517
Views
5
CrossRef citations to date
0
Altmetric
Clinical Research

Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4)

Betty S. ChanDepartment of Emergency Medicine, Clinical Toxicology Unit, Prince of Wales Hospital, Randwick, NSW, Australia; ;Queensland Poisons Information Centre, South Brisbane, Queensland, Australia; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-0083-282X
ORCID Icon,
Geoffrey K. IsbisterQueensland Poisons Information Centre, South Brisbane, Queensland, Australia; ;Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; ORCID Iconhttp://orcid.org/0000-0003-1519-7419
ORCID Icon,
Colin B. PageQueensland Poisons Information Centre, South Brisbane, Queensland, Australia; ;Clinical Toxicology Unit, Princess Alexandra Hospital, Queensland, Australia; ORCID Iconhttp://orcid.org/0000-0002-6924-8130
ORCID Icon,
Katherine Z. IsoardiQueensland Poisons Information Centre, South Brisbane, Queensland, Australia; ;Clinical Toxicology Unit, Princess Alexandra Hospital, Queensland, Australia; ORCID Iconhttp://orcid.org/0000-0002-1176-7923
ORCID Icon,
Angela L. ChiewDepartment of Emergency Medicine, Clinical Toxicology Unit, Prince of Wales Hospital, Randwick, NSW, Australia; ;Queensland Poisons Information Centre, South Brisbane, Queensland, Australia; ORCID Iconhttp://orcid.org/0000-0002-0079-5056
ORCID Icon,
Katharine A. KirbyDiscipline of Pharmacology, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia
&
Nicholas A. BuckleyQueensland Poisons Information Centre, South Brisbane, Queensland, Australia; ;Discipline of Pharmacology, School of Medical Sciences, University of Sydney, Sydney, NSW, AustraliaORCID Iconhttp://orcid.org/0000-0002-6326-4711
ORCID Icon show all
Pages 638-643 | Received 07 Sep 2018, Accepted 05 Nov 2018, Published online: 26 Dec 2018

References

  • January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130:2071–2104.
  • Ziff OJ, Lane DA, Samra M, et al. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ 2015;351:h4451.
  • Hussain Z, Swindle J, Hauptman PJ. Digoxin use and digoxin toxicity in the post-DIG trial era. J Card Fail. 2006;12:343–346.
  • Hauptman PJ, Blume SW, Lewis EF, et al. Digoxin toxicity and use of digoxin immune fab: insights from a national hospital database. JACC Heart Fail. 2016;4:357–364.
  • Lapostolle F, Borron SW, Verdier C, et al. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning. Crit Care Med. 2008;36:3014–3018.
  • Smith TW, Haber E, Yeatman L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976;294:797–800.
  • Arbabian H, Lee HM, Graudins A. Elderly patients with suspected chronic digoxin toxicity: a comparison of clinical characteristics of patients receiving and not receiving digoxin-Fab. Emerg Med Australas. 2018;30:242–248.
  • Chan BS, Isbister GK, O’Leary M, et al. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). Clin Toxicol. 2016;54:488–494.
  • Chan BS, Buckley NA. Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clin Toxicol. 2014;52:824–836.
  • DiDomenico RJ, Walton SM, Sanoski CA, et al. Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity. J Cardiovasc Pharmacol Ther. 2000;5:77–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.